Evidence map›Paper›PMID 32770104›Full record

ArticleScientific reports2020

Novel multiparameter correlates of Coxiella burnetii infection and vaccination identified by longitudinal deep immune profiling.

P M Reeves, S Raju Paul, L Baeten, S E Korek, Y Yi, J Hess, D Sobell, A Scholzen, A Garritsen, A S De Groot and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Cytometry in High-Containment Laboratories.Methods in molecular biology (Clifton, N.J.) · 2024
    Review
  2. Cytometry profiling ofFrontiers in immunology · 2023
    Article
  3. Article
  4. Preclinical Animal Models for Q Fever Vaccine Development.Frontiers in cellular and infection microbiology · 2022
    Review
  5. Soluble antigens derived fromCell reports. Medicine · 2021
    Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

P M ReevesVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, USA. pmreeves@mgh.harvard.edu.
S Raju PaulVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, USA.
L BaetenColorado State University, Fort Collins, CO, USA.
S E KorekVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, USA.
Y YiVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, USA.
J HessVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, USA.
D SobellVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, USA.
A ScholzenInnatOss Laboratories B.V, Oss, The Netherlands.
A GarritsenInnatOss Laboratories B.V, Oss, The Netherlands.
A S De GrootEpiVax, Inc, Providence, RI, USA.
L MoiseEpiVax, Inc, Providence, RI, USA.
T BraunsVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, USA.
R BowenColorado State University, Fort Collins, CO, USA.
A E SluderVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, USA.
M C PoznanskyVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, USA. mpoznansky@mgh.harvard.edu.
Massachusetts General Hospital · USColorado State University · USEpiVax (United States) · USUniversity of Georgia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Q-fever is a flu-like illness caused by Coxiella burnetii (Cb), a highly infectious intracellular bacterium. There is an unmet need for a safe and effective vaccine for Q-fever. Correlates of immune protection to Cb infection are limited. We proposed that analysis by longitudinal high dimensional immune (HDI) profiling using mass cytometry combined with other measures of vaccination and protection could be used to identify novel correlates of effective vaccination and control of Cb infection. Using a vaccine-challenge model in HLA-DR transgenic mice, we demonstrated significant alterations in circulating T-cell and innate immune populations that distinguished vaccinated from naïve mice within 10 days, and persisted until at least 35 days post-vaccination. Following challenge, vaccinated mice exhibited reduced bacterial burden and splenomegaly, along with distinct effector T-cell and monocyte profiles. Correlation of HDI data to serological and pathological measurements was performed. Our data indicate a Th1-biased response to Cb, consistent with previous reports, and identify Ly6C, CD73, and T-bet expression in T-cell, NK-cell, and monocytic populations as distinguishing features between vaccinated and naïve mice. This study refines the understanding of the integrated immune response to Cb vaccine and challenge, which can inform the assessment of candidate vaccines for Cb.

Indexed as

Immunity, CellularImmunity, InnateAnimalsBacterial VaccinesCoxiella burnetiiFemaleHLA-DR AntigensHumansKiller Cells, NaturalMiceMice, Inbred BALB CMice, TransgenicMonocytesQ FeverT-LymphocytesBacterial VaccinesHLA-DR Antigens

Identifiers

PMID32770104
PMCPMC7414860
OpenAlexW3048304511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.